<DOC>
	<DOC>NCT00704535</DOC>
	<brief_summary>The purpose of this study is to evaluate the overall safety, tolerability, and efficacy of Ezetimibe when used alone or in combination with a statin in patients with hypercholesterolemia</brief_summary>
	<brief_title>Evaluation of the Safety, Tolerability and Efficacy of Ezetimibe on a Select Population of Filipinos With Hypercholesterolemia (Study P04748)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type II</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Outpatient men or women, age 18 years and above. Patients with primary (heterozygous familial and nonfamilial) hypercholesterolemia or homozygous familial hypercholesterolemia. Known hypersensitivity to Ezetimibe. Moderate to severe hepatic insufficiency. Persistent elevation of serum transaminase levels of more than 1.5 times the upper limit of normal. Pregnancy or lactation. Concomitant intake of bile acid sequestrants (resins), nicotinic acid (niacin), fibric acid (fibrates), or cyclosporine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>